NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 7.90% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 7.45% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.37% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.27% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.67% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.28% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 3.74% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.73% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.61% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.60% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.53% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.52% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.37% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.05% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.99% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 2.73% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.29% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.77% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.62% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.31% |